top of page
Researcher

ABOUT-MDRO

Start Date:

June 2018

End Date:

June 2021

Duration:

36 months

ID-CARE Role:
Website:

Partner

Description

Title: Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe Design: Systematic review 


Primary Objective: A systematic review on the burden and outcomes of infections due to multidrug resistant organisms (MDRO) to provide estimations of the burden of some key infections and their outcomes caused by the target MDROs. Crude and infection-attributable mortality and length of hospital stay (overall and in intensive care units). Mortality will be collected as defined in each study, but the primary intention is to analyse in-hospital, 14-day, 30-day and 90-day mortalities. In addition, length of stay will be collected as defined in the studies. 

Partners

University of Verona - ITALY

IBiS Instituto de Biomedicina de Sevilla - SPAIN

Universidad de Sevilla - SPAIN

Universitario Virgen Macarena - SPAIN

Sponsor
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Publications

BMJ Open

4/5/20

Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol

ID-CARE Participants

Evelina Tacconelli

Director

Maria Diletta Pezzani

Medical Doctor

From our Blog
In the News
bottom of page